McKesson Analyst Ratings
Dow Jumps Over 1,500 Points To A New High After Trump Win: Investor Sentiment Improves, Fear & Greed Index Moves To 'Neutral' Zone
McKesson Sees FY25 Adj EPS $32.40-$33.00 Vs $31.75-$32.55 Est
McKesson Q2 2025 Adj EPS $7.07 Beats $6.88 Estimate, Sales $93.70B Beat $89.33B Estimate
SA Asks: How Will the U.S. Election Results Impact Healthcare Stocks?
GoodRx Accused of Conspiring With PBMs Over Reimbursement Fees
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Evercore ISI Group Maintains Outperform on Coca-Cola Europacific, Raises Price Target to $82
Coca-Cola Europacific Analyst Ratings
Mercury Systems Posts Strong Results, Joins ArcBest, Tesla, Kennametal, Qualys And Other Big Stocks Moving Higher On Wednesday
Here Are the Major Earnings After the Close Today
Altria Group Analyst Ratings
Health Insurers Climb After Trump Win
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday as Investors Digest Trump Win
Winners and Losers in the Tobacco Sector Under a Trump Administration
Celsius Holdings Falls After Reporting Large Drops in Revenue and EBITDA
CVS Health in Charts: Health Care Benefits Segment Revenues Hits $33B, +25.5% Y/Y
Dow, Nasdaq Futures Race Higher As Trump Wins White House: DJT, Tesla Shares Surge — Veteran Investor Predicts US Economy Could 'Take Off'
CVS Shares Are Trading Higher Following a Q3 Revenue Beat.
CVS Health Non-GAAP EPS of $1.09 Misses by $0.37, Revenue of $95.43B Beats by $2.74B